MiLaboratories

📍 San Francisco, United States🗓 Founded 2021👥 18 employees💰 Last funded Jul 2024
Biotechnology Research🌐 milaboratories.com
Website LinkedIn
MiXCR is an ultimate software platform for analysis of Next-Generation Sequencing (NGS) data for immune profiling. It’s widely used to empower R&D in vaccine development, CAR-T therapies, antibody discovery and other areas. 8 out of 10 Big Pharma companies choose MiXCR for studying immune system. Aiming to support non-profit research, we provide MiXCR for free for academic and non-commercial use. For years, MiXCR is being the number one solution for immune system studies in academia and industry.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Arab Emirates
1
Frequently asked questions
Who invested in MiLaboratories?
MiLaboratories has 1 investors on record on gritt.io, 1 mid-stage.
When did MiLaboratories last raise funding?
The most recent investment in MiLaboratories recorded on gritt.io was in July 2024.
When was MiLaboratories founded?
MiLaboratories was founded in 2021.
What industry is MiLaboratories in?
MiLaboratories operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MiLaboratories based?
MiLaboratories is headquartered in San Francisco, United States.